BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 23475537)

  • 1. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
    Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
    Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
    Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
    Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Subacute cerebellar degeneration and pleural mesothelioma. Report of a case].
    Tassinari D; Sartori S; Arcangeli V; Drudi G; Panzini I; Pasini G; Ravaioli A
    Recenti Prog Med; 2000 Jun; 91(6):301-2. PubMed ID: 11512388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
    Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
    PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
    Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K; Tanaka M; Onodera O; Tsuji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma.
    Valpione S; Zoccarato M; Parrozzani R; Pigozzo J; Giometto B; Laveder F; Aliberti C; Chiarion-Sileni V
    J Neurol Sci; 2013 Dec; 335(1-2):210-2. PubMed ID: 24035275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Ri-associated paraneoplastic cerebellar degeneration. Report of a case and revision of the literature.
    Mancuso M; Orsucci D; Bacci A; Caldarazzo Ienco E; Siciliano G
    Arch Ital Biol; 2011 Sep; 149(3):318-22. PubMed ID: 22028093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic cerebellar degeneration with anti-Yo antibody in a patient with HER2/neu overexpressing breast cancer: a case report with a current literature review.
    Ogita S; Llaguna OH; Feldman SM; Blum R
    Breast J; 2008; 14(4):382-4. PubMed ID: 18540952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
    Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
    Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic neurological syndrome: patient with anti-Yo antibody and breast cancer: a case report.
    Dorn C; Knobloch C; Kupka M; Morakkabati-Spitz N; Schmolling J
    Arch Gynecol Obstet; 2003 Nov; 269(1):62-5. PubMed ID: 14605824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction.
    Debes JD; Lagarde SM; Hulsenboom E; Sillevis Smitt PA; ten Kate FJ; Sulter GA; van Lanschot JJ
    Dig Surg; 2007; 24(5):395-7. PubMed ID: 17785986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration.
    Finsterer J; Voigtländer T; Grisold W
    J Neurol Sci; 2011 Sep; 308(1-2):139-41. PubMed ID: 21762925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Yo positive paraneoplastic cerebellar degeneration in the setting of cholangiocarcinoma.
    Bruhnding A; Notch D; Beard A
    J Clin Neurosci; 2017 Feb; 36():71-72. PubMed ID: 27816258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review.
    Key RG; Root JC
    Psychooncology; 2013 Sep; 22(9):2152-5. PubMed ID: 23585287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Yo antibody associated with occult fallopian tube carcinoma.
    Selby KJ; Warner J; Klempner S; Konstantinopoulos PA; Hecht JL
    Int J Gynecol Pathol; 2011 Nov; 30(6):536-8. PubMed ID: 21979588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paraneoplastic cerebellar degeneration with bladder cancer confirmed the existence of an anti-neural antibody: a case report].
    Kawanishi K; Morita M; Nakahara K; Tetsuka S; Kouki T; Tominaga K; Endo H; Yashiro T; Tanaka K; Nakano I
    Brain Nerve; 2013 Nov; 65(11):1401-5. PubMed ID: 24200618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
    Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
    Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paraneoplastic neurologic degeneration revealing ovarian cancer recurrence].
    Zouiten O; Benbrahim Z; Amaadour L; Mellas N
    Pan Afr Med J; 2019; 33():281. PubMed ID: 31692829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.
    Xia K; Saltzman JR; Carr-Locke DL
    MedGenMed; 2003 Aug; 5(3):18. PubMed ID: 14600654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.